What antiemetic and dosing is recommended for a 20‑month‑old child (approximately 12 kg)?

Ondansetron is the recommended antiemetic for a 20-month-old child

For a 20-month-old child (approximately 12 kg), ondansetron at 0.1 mg/kg IV (1.2 mg) or 0.15 mg/kg orally (1.8 mg) is the first-line antiemetic. This recommendation applies to the most common pediatric indication—acute gastroenteritis with vomiting—where ondansetron has the strongest evidence base.

Dosing Specifics

Ondansetron dosing for this age group:

• Intravenous/Intraosseous: 0.1 mg/kg (1.2 mg for a 12 kg child) given as a single dose 1
• Oral (disintegrating tablet preferred): 0.15 mg/kg, though doses ranging from 0.13-0.26 mg/kg show similar efficacy 2
• Alternative weight-based oral dosing: For children <15 kg, some protocols use fixed 2 mg doses, though weight-based dosing is more precise at this age

The evidence strongly supports that a single dose is typically sufficient for acute gastroenteritis 3, 4. Ondansetron reduces vomiting episodes by approximately 60% (relative risk 0.40), decreases need for IV rehydration by 54% (relative risk 0.46), and facilitates oral rehydration 3.

Clinical Context Matters

The indication determines the approach:

For acute gastroenteritis (most common):

• Single dose of ondansetron as above
• Administer after initial assessment confirms dehydration but before oral rehydration attempts
• Do not use routinely for minimal vomiting without dehydration 5

For chemotherapy-induced nausea/vomiting:

• Higher dosing applies: 5 mg/m² or 0.15 mg/kg IV 6, 7
• Typically combined with dexamethasone for moderate-to-high emetogenic chemotherapy
• This is a specialized oncology setting requiring different protocols 8

For postoperative nausea/vomiting:

• 0.1 mg/kg IV given prophylactically before surgery 1
• Efficacy demonstrated in children as young as 1 month

Important Safety Considerations

Ondansetron is generally safe in this age group with minimal adverse effects 1, 3. However:

• Diarrhea may increase as a side effect—this is the most common concern and may increase stool output 5, 9
• Monitor for QTc prolongation if the child is on other QT-prolonging medications (rare concern in otherwise healthy children)
• Sedation is minimal compared to older antiemetics like promethazine

What NOT to Use

Avoid these agents in a 20-month-old:

• Loperamide or other antimotility agents: Contraindicated in children <18 years with acute diarrhea due to risk of ileus, lethargy, and reported deaths in young children 5
• Promethazine: Higher sedation risk and dystonic reactions 6
• Metoclopramide: Significant risk of extrapyramidal reactions in young children 6

Alternative if Ondansetron Unavailable

If ondansetron is not available or contraindicated:

• Dimenhydrinate has been used historically but with more sedation
• Granisetron (another 5-HT3 antagonist) at 0.01 mg/kg or 10 mcg/kg once daily 6, 8
• Focus on oral rehydration therapy without antiemetics if vomiting is mild

Practical Algorithm

1. Assess severity: Mild vomiting without dehydration → oral rehydration alone, no antiemetic needed
2. Moderate vomiting with dehydration: Single dose ondansetron 0.1 mg/kg IV or 0.15 mg/kg PO
3. Administer oral rehydration 30-60 minutes after ondansetron
4. Reassess at 4-8 hours: Most children respond to single dose; repeat dosing rarely needed and not well-studied in gastroenteritis 4
5. If persistent vomiting despite ondansetron: Consider IV rehydration rather than additional antiemetic doses

The evidence strongly supports ondansetron as safe and effective in this age group, with the caveat that it should facilitate—not replace—appropriate rehydration therapy 5, 3, 9.